Q-omics provides the consensus-scored C2orf81 profile across patient tissues and cancer cell-line models. Additionally, C2orf81 RNA expression shows 9,139 significant protein co-abundance associations, with the highest sampling consensus in BRCA.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for C2orf81 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with C2orf81 in patient tissues and cancer cell lines. In patient samples, C2orf81 shows the broadest associations at the RNA and protein expression levels, with BRCA recurring as the lineage with the largest associated feature set. In cancer cell lines, C2orf81 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in SOFT_TISSUE, while CRISPR and shRNA rows add functional-dependency signals in BLOOD_Leukemia and LARGE_INTESTINE.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	9,139	BRCA (2507)	view →
Function (mass-spec)	577	BRCA (148)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	10,082	SOFT_TISSUE (2775)	view →
Function (RNA)	4,073	BLOOD_Leukemia (769)	view →
▼Mutation
Mutation	4,841	LARGE_INTESTINE (4571)	view →
RNA	31	LARGE_INTESTINE (24)	view →
▼shRNA
shRNA	1,752	CNS (175)	view →
RNA	1,578	LUNG_SCLC (431)	view →